One of the better punts for 2015

CYP is just about to bed down options exercise ( fully underwritten) and hence will be cashed up.
Has had a relatively small trading range over last 12 months with little volatility compared to overall market
Biotech sector doing OK
Has some significant " market players" on board and stock pretty tightly held - difficult to get a decent amount without pushing price up significantly.
Been slightly more than 12 months since CYP emerged recapitalised
Stem cell stuff the way medical advancement is occurring

Any way just my simple ramblings
DYOR and maybe not best to wait until FOMO time

Have fun